This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (11)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Psychopharmacology  • Psychiatry, Other  • Alert me on articles by topic

Arch Gen Psychiatry. 2000;57:323-324.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

ALTHOUGH their primary concerns were the safety and ethics of placebo use, Khan et al¹ also used the Food and Drug Administration files on second-generation antidepressants to assess "symptom reduction among patients assigned to antidepressants and placebo." In this sample of approximately 19 000 patients, placebo and drug had comparable morbidity and mortality and the authors report that "symptom reduction was 40.7% with investigational . . . 41.7% with active comparators . . . and 30.9% with placebo. . . . "

We believe that these data can appropriately assess morbidity but do not adequately assess efficacy. The only data available were pretreatment and posttreatment mean total Hamilton Depression Rating scores, most without SEs. Although constrained by database inadequacies, effect size estimates were calculated and Khan et al report that "nearly half the studies had less than medium effect size (<0.5)."

Khan et al also note the limitations in drawing . . . [Full Text of this Article]

RELATED ARTICLES

Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical Trials: An Analysis of the Food and Drug Administration Database
Arif Khan, Heather A. Warner, and Walter A. Brown
Arch Gen Psychiatry. 2000;57(4):311-317.
ABSTRACT | FULL TEXT  

Placebo Controls: No News Is Good News
Paul Leber
Arch Gen Psychiatry. 2000;57(4):319-320.
EXTRACT | FULL TEXT  

The Placebo Problem Remains
Karin B. Michels
Arch Gen Psychiatry. 2000;57(4):321-322.
EXTRACT | FULL TEXT  

Suicide and Antidepressant Treatment
Robert M. A. Hirschfeld
Arch Gen Psychiatry. 2000;57(4):325-326.
EXTRACT | FULL TEXT  

Statistical Analysis to Settle Ethical Issues?
Helena Chmura Kraemer
Arch Gen Psychiatry. 2000;57(4):327-328.
EXTRACT | FULL TEXT  

Placebo Protects Subjects From Nonresponse: A Paradox of Power
Andrew C. Leon
Arch Gen Psychiatry. 2000;57(4):329-330.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ethical aspects of placebo groups in pain trials: Lessons from psychiatry
Nagasako and Kalauokalani
Neurology 2005;65:S59-S65.
ABSTRACT | FULL TEXT  

Neurobiological Mechanisms of the Placebo Effect
Benedetti et al.
J. Neurosci. 2005;25:10390-10402.
FULL TEXT  

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents
Olfson et al.
Arch Gen Psychiatry 2003;60:978-982.
ABSTRACT | FULL TEXT  

The Functional Neuroanatomy of the Placebo Effect
Mayberg et al.
Am. J. Psychiatry 2002;159:728-737.
ABSTRACT | FULL TEXT